FPH.AX - Fisher & Paykel Healthcare Corporation Limited

ASX - ASX Delayed price. Currency in AUD
12.57
+0.17 (+1.37%)
As of 3:06PM AEDT. Market open.
Stock chart is not supported by your current browser
Previous close12.40
Open12.35
Bid12.56 x 83900
Ask12.57 x 30000
Day's range12.29 - 12.58
52-week range7.84 - 12.58
Volume188,042
Avg. volume563,787
Market cap7.362B
Beta1.16
PE ratio (TTM)60.72
EPS (TTM)0.21
Earnings dateN/A
Forward dividend & yield0.16 (2.94%)
Ex-dividend date2016-12-06
1y target est8.30
  • Why the ResMed Inc. (CHESS) share price is falling today
    Motley Fool3 days ago

    Why the ResMed Inc. (CHESS) share price is falling today

    Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) v ResMed Inc. (CHESS) (ASX:RMD) remains a legal gravy train.

  • Why Fisher & Paykel Healthcare Corp Ltd is racking up the legal costs
    Motley Fool24 days ago

    Why Fisher & Paykel Healthcare Corp Ltd is racking up the legal costs

    Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) may face issues if the North American Free Trade Agreement is re-negotiated.

  • 8 shares to watch this week
    Motley Fool25 days ago

    8 shares to watch this week

    Shares to watch this week including Woolworths Limited (ASX:WOW), a2 Milk Company Ltd (Australia) (ASX:A2M) and REA Group Limited (ASX:REA).

  • AAPlast month

    Fisher & Paykel wins patent court case

    Fisher & Paykel Healthcare has won a patent case against rival medical products manufacturer ResMed, after a court in the United Kingdom ruled the patent claim invalid. In 2016, New Zealand-based Fisher & Paykel sought a declaration from the High Court that three of ResMed's European patents were invalid in the UK and should be revoked. ResMed revoked two of its patents in the UK just before the trial was due to start, but left one for consideration by the High Court's patents division.